- Investing Ideas
- /
- Indian Undervalued Stocks Based On Cash Flows
Indian Undervalued Stocks Based On Cash Flows
Results
29
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
29 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
500163 | ₹4,533.25 | 2.4% | 106.4% | ₹225.7b | ₹4,689.00 | PE27.5x | E23.8% | 1.2% | Food, Beverage & Tobacco | ||
524164 | ₹391.70 | -4.2% | 6.8% | ₹22.7b | ₹471.00 | PE19.4x | E22.2% | 1.3% | Pharmaceuticals & Biotech | ||
UDS | ₹320.00 | -3.8% | n/a | ₹20.5b | ₹410.33 | PE26.6x | E36.1% | n/a | Commercial Services | ||
EKC | ₹169.18 | 7.5% | 55.4% | ₹18.8b | ₹158.00 | PE18x | E27.5% | 0.4% | Materials | ||
KRSNAA | ₹658.20 | -5.4% | 24.7% | ₹21.3b | ₹892.00 | PE35.4x | E36.9% | 0.4% | Healthcare | ||
DIAMONDYD | ₹894.40 | 1.5% | 1.4% | ₹19.9b | ₹1,066.00 | PE43.5x | E25.2% | 0.2% | Food, Beverage & Tobacco | ||
TARSONS | ₹423.15 | -13.8% | -18.2% | ₹24.2b | ₹570.50 | PE61.4x | E24.0% | 0.5% | Pharmaceuticals & Biotech | ||
531120 | ₹54.69 | 1.6% | 0.02% | ₹43.2b | ₹80.00 | PE15.3x | E20.1% | n/a | Capital Goods | ||
RITES | ₹655.45 | -4.3% | 44.8% | ₹157.2b | ₹708.75 | PE36.9x | E23.5% | 2.7% | Commercial Services | ||
PPLPHARMA | ₹182.08 | 0.3% | 84.3% | ₹242.3b | ₹197.50 | PE869.6x | E73.5% | 0.06% | Pharmaceuticals & Biotech | ||
SCHAND | ₹214.62 | -4.8% | 7.3% | ₹7.7b | ₹312.00 | PE14.5x | E31.6% | 1.4% | Media | ||
STAR | ₹1,312.85 | 14.9% | 217.0% | ₹112.8b | ₹1,219.33 | PS2.9x | E98.3% | 0.2% | Pharmaceuticals & Biotech | ||
NIITMTS | ₹462.45 | -1.8% | 28.6% | ₹62.2b | ₹548.33 | PE28.8x | E18.3% | 1.2% | Consumer Services | ||
ORCHPHARMA | ₹1,398.65 | -10.7% | 160.4% | ₹70.5b | ₹1,525.33 | PE63.3x | E43.7% | n/a | Pharmaceuticals & Biotech | ||
TITAGARH | ₹1,427.95 | 5.9% | 124.5% | ₹190.4b | ₹1,798.20 | PE65.5x | E30.1% | 0.06% | Capital Goods | ||
IRB | ₹62.84 | 1.4% | 143.1% | ₹377.8b | ₹72.00 | PE62x | E32.0% | 0.5% | Capital Goods | ||
FUSION | ₹284.85 | -6.8% | -49.0% | ₹29.1b | ₹446.80 | PE8.2x | E24.7% | n/a | Diversified Financials | ||
506655 | ₹983.15 | 1.2% | 97.2% | ₹67.0b | ₹945.22 | PE56.8x | E33.3% | 0.5% | Materials | ||
506235 | ₹141.70 | -1.7% | 77.4% | ₹36.0b | ₹1,396.00 | PE13x | E40.8% | 1.7% | Real Estate Management and Development | ||
JINDALSTEL | ₹934.50 | 2.0% | 45.8% | ₹948.4b | ₹1,021.13 | PE17x | E24.1% | 0.2% | Materials | ||
533286 | ₹406.65 | -7.9% | 97.2% | ₹83.3b | ₹484.50 | PE23x | E36.5% | 1.5% | Materials | ||
517544 | ₹1,558.55 | -2.4% | 10.9% | ₹19.4b | ₹1,776.00 | PS1.8x | E112.9% | 0.4% | Tech | ||
ARVINDFASN | ₹475.50 | -1.3% | 56.0% | ₹62.2b | ₹596.80 | PE93.4x | E46.9% | 0.3% | Retail | ||
BLUEJET | ₹460.60 | -3.2% | n/a | ₹79.9b | ₹523.33 | PE50.8x | E25.6% | 0.2% | Pharmaceuticals & Biotech |